Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA grants nivolumab breakthrough therapy designation for Hodgkin's lymphoma

May 15, 2014

FDA grants fast track status to Prima BioMed's CVac program

May 12, 2014

Cellmid selects lead anti-MK antibody in oncology

May 12, 2014

PSMA MAb [177Lu]J-591 tested for treatment of metastatic solid tumors

May 12, 2014

New anticancer agents patented by Chinese scientists

May 9, 2014

Mologen files clinical trial applications for phase III trial of anticancer immunostimulant

May 8, 2014

FDA accepts MK-3475 BLA for review in advanced melanoma

May 8, 2014

IDH1 gene mutation-specific vaccine developed for treatment of patients with glioma

May 8, 2014

Advaxis' immunotherapy product to enter clinic for pediatric bone cancer

May 6, 2014

FDA grants orphan drug designation to OncoMed's demcizumab for pancreatic cancer

May 5, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...